If Jemperli is approved, it will bring new market opportunit...
If Jemperli is approved, it will bring new market opportunities to GlaxoSmithKline, particularly in a new therapeutic field, which could have a positive impact on the company's drug sales.
GlaxoSmithKline (GSK.US): EU CHMP recommends approval of Jemperli+ chemotherapy for certain endometrial cancers
Disclaimer: The above information does not represent the views of Moomoo Technologies Inc. (MTI) or constitute investment advice related to MTI and its affiliates.
Read more
Comment
Sign in to post a comment